-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
16,489 Shares in Cerus Co. (NASDAQ:CERS) Purchased by Cetera Advisors LLC
16,489 Shares in Cerus Co. (NASDAQ:CERS) Purchased by Cetera Advisors LLC
Cetera Advisors LLC purchased a new stake in Cerus Co. (NASDAQ:CERS – Get Rating) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 16,489 shares of the biotechnology company's stock, valued at approximately $91,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. ARK Investment Management LLC grew its holdings in Cerus by 2.9% in the 1st quarter. ARK Investment Management LLC now owns 16,213,847 shares of the biotechnology company's stock valued at $89,014,000 after buying an additional 455,803 shares during the period. Senvest Management LLC grew its holdings in Cerus by 41.3% in the 4th quarter. Senvest Management LLC now owns 3,648,314 shares of the biotechnology company's stock valued at $24,845,000 after buying an additional 1,066,600 shares during the period. D. E. Shaw & Co. Inc. grew its holdings in Cerus by 47.4% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,445,372 shares of the biotechnology company's stock valued at $16,653,000 after buying an additional 786,686 shares during the period. Tamarack Advisers LP grew its holdings in Cerus by 65.0% in the 1st quarter. Tamarack Advisers LP now owns 1,650,000 shares of the biotechnology company's stock valued at $9,059,000 after buying an additional 650,000 shares during the period. Finally, Peregrine Capital Management LLC grew its holdings in Cerus by 12.7% in the 1st quarter. Peregrine Capital Management LLC now owns 1,482,436 shares of the biotechnology company's stock valued at $8,139,000 after buying an additional 167,581 shares during the period. Hedge funds and other institutional investors own 84.72% of the company's stock.
Get Cerus alerts:Cerus Stock Up 3.6 %
CERS opened at $4.07 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.73. The stock has a market capitalization of $720.76 million, a price-to-earnings ratio of -16.96 and a beta of 1.14. The business has a 50-day moving average of $5.13 and a two-hundred day moving average of $5.15. Cerus Co. has a 12 month low of $3.85 and a 12 month high of $8.06.
Insider Transactions at Cerus
In other news, insider Richard J. Benjamin sold 10,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the completion of the sale, the insider now owns 172,665 shares in the company, valued at approximately $884,044.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 7.33% of the company's stock.About Cerus
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Featured Stories
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Cetera Advisors LLC purchased a new stake in Cerus Co. (NASDAQ:CERS – Get Rating) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 16,489 shares of the biotechnology company's stock, valued at approximately $91,000.
根據Cerus Co.(納斯達克代碼:CERS-GET Rating)最近提交給美國證券交易委員會的13F文件,該公司在今年第一季度購入了該公司新的股份。該基金購買了這家生物技術公司的16,489股股票,價值約91,000美元。
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. ARK Investment Management LLC grew its holdings in Cerus by 2.9% in the 1st quarter. ARK Investment Management LLC now owns 16,213,847 shares of the biotechnology company's stock valued at $89,014,000 after buying an additional 455,803 shares during the period. Senvest Management LLC grew its holdings in Cerus by 41.3% in the 4th quarter. Senvest Management LLC now owns 3,648,314 shares of the biotechnology company's stock valued at $24,845,000 after buying an additional 1,066,600 shares during the period. D. E. Shaw & Co. Inc. grew its holdings in Cerus by 47.4% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,445,372 shares of the biotechnology company's stock valued at $16,653,000 after buying an additional 786,686 shares during the period. Tamarack Advisers LP grew its holdings in Cerus by 65.0% in the 1st quarter. Tamarack Advisers LP now owns 1,650,000 shares of the biotechnology company's stock valued at $9,059,000 after buying an additional 650,000 shares during the period. Finally, Peregrine Capital Management LLC grew its holdings in Cerus by 12.7% in the 1st quarter. Peregrine Capital Management LLC now owns 1,482,436 shares of the biotechnology company's stock valued at $8,139,000 after buying an additional 167,581 shares during the period. Hedge funds and other institutional investors own 84.72% of the company's stock.
其他幾家對衝基金和其他機構投資者最近也增持或減持了該業務的股份。方舟投資管理有限責任公司第一季度增持Cerus股份2.9%。方舟投資管理有限責任公司現在擁有16,213,847股生物技術公司的股票,價值89,014,000美元,在此期間又購買了455,803股。Senvest Management LLC在第四季度增持了41.3%的Cerus股份。Senvest Management LLC現在擁有這家生物技術公司3,648,314股股票,價值24,845,000美元,在此期間又購買了1,066,600股。D.E.Shaw&Co.Inc.在第四季度增持了Cerus 47.4%的股份。D.E.Shaw&Co.Inc.現在持有這家生物技術公司2,445,372股股票,價值16,653,000美元,在此期間又購買了786,686股。Tamarack Advisers LP在第一季度增持Cerus股份65.0%。Tamarack Advisers LP現在擁有這家生物技術公司165萬股票,價值905.9萬美元,在此期間又購買了65萬股票。最後,百富勤資本管理有限責任公司在第一季度增持了12.7%的Cerus股份。百富勤資本管理有限責任公司現在擁有這家生物技術公司1,482,436股,價值8,139,000美元,在此期間又購買了167,581股。對衝基金和其他機構投資者持有該公司84.72%的股票。
Cerus Stock Up 3.6 %
Cerus股價上漲3.6%
CERS opened at $4.07 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.73. The stock has a market capitalization of $720.76 million, a price-to-earnings ratio of -16.96 and a beta of 1.14. The business has a 50-day moving average of $5.13 and a two-hundred day moving average of $5.15. Cerus Co. has a 12 month low of $3.85 and a 12 month high of $8.06.
CER週四開盤報4.07美元。該公司的債務權益比為0.53,流動比率為2.08,速動比率為1.73。該股市值為7.2076億美元,市盈率為-16.96倍,貝塔係數為1.14。該業務的50日移動均線切入位在5.13美元,200日移動均線切入位在5.15美元。Cerus Co.的12個月低點為3.85美元,12個月高位為8.06美元。
Insider Transactions at Cerus
Cerus的內幕交易
About Cerus
關於Cerus
(Get Rating)
(獲取評級)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物醫藥產品公司。該公司專注於開發攔截血液系統並將其商業化,以增強血液安全。其攔截血液系統,這是一項控制生物複製的專利技術,旨在減少用於輸血的捐獻血液成分中的血源性病原體。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
- 免費獲取StockNews.com關於Cerus的研究報告(CERS)
- 3家高利潤率芯片製造商勢必復甦
- 將受益於拜登關税假期的3只太陽能股
- REV集團在電動汽車世界擁有深厚的護城河
- G-III服裝集團有限公司是價值陷阱嗎?
- 美國銀行看好這兩隻歐洲酒類股票
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cerus和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧